目的 探讨特异性快速脱敏治疗对过敏性鼻炎的治疗效果及其安全性.方法 对95例过敏性鼻炎患者采用标准化特异性快速脱敏治疗2~3年的患者进行评价.结果 总有效率为92.6%,未见严重全身或局部过敏反应.结论 快速脱敏治疗是一种安全,有效的病因治疗方法,且疗程短,病人容易接受,值得临床推广使用.%To study the relation of childhood bronchial asthma with mycoplasma pneumoniae infection. Methods 202 children with asthma attacks and 202 children with upper respiratory tract infection were analyzed, using enzyme-linked immunosorbent assay (EIAS) detection, use (EIA) enzyme-linked immunosorbent method half quantitative measurement of serum IgM myooplasma antibodies. Results There were 102 (50.5%) and 48 cases (23.8%) in asthma group and respiratory tract infection group with positive mycoplasma pneumoniae antibody, and there were a significant difference between two groups (p<0.01). Conclusion There were a close relationship between pneumoniae infection and childhood bronchial asthma, and myeoplasma pneumoniae antibody examination should be performed for children with asthma.
展开▼